Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Nuclear oncology as seen by me in Japan: a historical review and future perspective.

Sasaki Y.

Ann Nucl Med. 2019 Oct 30. doi: 10.1007/s12149-019-01413-1. [Epub ahead of print] Review.

PMID:
31667714
3.

Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!

Høilund-Carlsen PF.

Hell J Nucl Med. 2018 Jan-Apr;21(1):85-87. doi: 10.1967/s002449910713. Epub 2018 Mar 20.

4.

Responding to the challenges of breast cancer in egypt and other arab countries.

El Saghir NS.

J Egypt Natl Canc Inst. 2008 Dec;20(4):309-12.

5.

Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.

Arai H, Ouchi Y, Toba K, Endo T, Shimokado K, Tsubota K, Matsuo S, Mori H, Yumura W, Yokode M, Rakugi H, Ohshima S.

Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.

PMID:
25656311
6.
7.

An introduction to the clinical practice of theranostics in oncology.

Turner JH.

Br J Radiol. 2018 Nov;91(1091):20180440. doi: 10.1259/bjr.20180440. Epub 2018 Sep 4. Review.

8.

The bright future of radionuclides for cancer therapy.

Nijsen JF, Krijger GC, van Het Schip AD.

Anticancer Agents Med Chem. 2007 May;7(3):271-90. Review.

PMID:
17504155
9.

Recent advances in theranostics and challenges for the future.

Turner JH.

Br J Radiol. 2018 Nov;91(1091):20170893. doi: 10.1259/bjr.20170893. Epub 2018 Mar 29. Review.

10.

Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.

Bombardieri E, Seregni E, Villano C, Chiti A, Bajetta E.

Q J Nucl Med Mol Imaging. 2004 Jun;48(2):150-63. Review.

11.

Current applications and perspectives of diagnostic nuclear medicine in oncology. Task Group of Oncology.

Bombardieri E, Carrio I, Gonzalez P, Serafini A, Turner JH, Virgolini I, Maffioli L.

Int J Oncol. 1999 May;14(5):877-90.

PMID:
10200337
12.

Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.

Jalilian AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, Geramifar P, Eftekhari M.

Semin Nucl Med. 2016 Jul;46(4):340-58. doi: 10.1053/j.semnuclmed.2016.01.006. Review. Erratum in: Semin Nucl Med. 2016 Nov;46(6):481.

PMID:
27237443
13.

[Future directions of anticancer drug development in Japan].

Akaza H, Kawai K, Tsuruo T, Tsukagoshi S, Aiba K, Shimada Y, Kakeji Y, Ishikawa H, Ikeda T, Nakamura S, Tamura T, Yamamoto N, Isonishi S, Hinotsu S, Hirose M, Katsura J.

Gan To Kagaku Ryoho. 2008 Feb;35(2):351-60. Japanese.

PMID:
18281781
14.

Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.

Langbein T, Weber WA, Eiber M.

J Nucl Med. 2019 Sep;60(Suppl 2):13S-19S. doi: 10.2967/jnumed.118.220566.

PMID:
31481583
15.
16.

On the Way to New Horizons: Telemedicine in Oncology.

Schlag PM.

Oncologist. 1997;2(2):III-IV.

18.

Introduction of nuclear medicine research in Japan.

Inubushi M, Higashi T, Kuji I, Sakamoto S, Tashiro M, Momose M.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2449-2452. Epub 2016 Aug 4.

19.

Paradigm shift in theranostics of neuroendocrine tumors: conceptual horizons of nanotechnology in nuclear medicine.

Arora G, Bandopadhyaya G.

Ann Nucl Med. 2018 Apr;32(3):151-164. doi: 10.1007/s12149-018-1235-2. Epub 2018 Jan 27. Review.

PMID:
29374820
20.

Theranostics in Bangladesh: Current Status, Challenges, and Future Perspective.

Ferdousi Begum SM, Nisa L, Sarker AK.

Nucl Med Mol Imaging. 2019 Apr;53(2):102-107. doi: 10.1007/s13139-019-00590-1. Epub 2019 Apr 2.

PMID:
31057681

Supplemental Content

Support Center